Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy

European Urology

Volumn 60, Issue 6, 2011, Pages 1142-1148

  Goenka, Anuj ^a   Magsanoc, Juan Martin ^a   Pei, Xin ^a   Schechter, Michael ^a   Kollmeier, Marisa ^a   Cox, Brett ^a   Scardino, Peter T ^a   Eastham, James A ^a   Zelefsky, Michael J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Erectile dysfunction; Gastrointestinal toxicity; Intensity modulated radiation therapy; Postprostatectomy salvage radiation therapy; Urinary incontinence; Urinary strictures; Urinary toxicity

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ACUTE TOXICITY; ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CHRONIC TOXICITY; CONTROLLED STUDY; ERECTILE DYSFUNCTION; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEPHROTOXICITY; POSTOPERATIVE CARE; POSTPROSTATECTOMY SALVAGE RADIATION THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; RISK REDUCTION; THREE DIMENSIONAL CONFORMAL RADIATION THERAPY; URETHRA STRICTURE; URINE INCONTINENCE; UROGENITAL TRACT DISEASE;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; GASTROINTESTINAL DISEASES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MALE UROGENITAL DISEASES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEW YORK CITY; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIATION DOSAGE; RADIATION INJURIES; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SALVAGE THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 80255127509     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.08.006     Document Type: Article

References (26)

1. A.J. Stephenson, S.F. Shariat, and M.J. Zelefsky Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy JAMA 291 2004 1325 1332 (Pubitemid 38541647)
2. T.M. Pisansky, T.F. Kozelsky, and R.P. Myers Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer J Urol 163 2000 845 850 (Pubitemid 30091629)
3. S.J. Buskirk, T.M. Pisansky, and S.E. Schild Salvage radiotherapy for isolated prostate specific antigen increase after radical prostatectomy: evaluation of prognostic factors and creation of a prognostic scoring system J Urol 176 2006 985 990 (Pubitemid 44160708)
4. S.B. Hayes, and A. Pollack Parameters for treatment decisions for salvage radiation therapy J Clin Oncol 23 2005 8204 8211 (Pubitemid 46211556)
5. J.D. Cox, M.J. Gallagher, and E.H. Hammond Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel J Clin Oncol 17 1999 1155
6. B.S. Teh, C.M. Amosson, and W.Y. Mai Intensity modulated radiation therapy (IMRT) in the management of prostate cancer Cancer Invest 22 2004 913 924 (Pubitemid 39665356)
7. B.S. Teh, W.Y. Mai, and M.E. Augspurger Intensity modulated radiation therapy (IMRT) following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer Int J Radiat Oncol Biol Phys 49 2001 465 472 (Pubitemid 32123611)
8. O. Cahlon, M. Hunt, and M.J. Zelefsky Intensity-modulated radiation therapy: supportive data for prostate cancer Semin Radiat Oncol 18 2008 48 57 (Pubitemid 350235956)
9. O. Cahlon, M.J. Zelefsky, and A. Shippy Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes Int J Radiat Oncol Biol Phys 71 2008 330 337
10. G. De Meerleer, L. Vakaet, and S. Meersschout Intensity-modulated radiotherapy as primary treatment for prostate cancer: acute toxicity in 114 patients Int J Radiat Oncol Biol Phys 60 2004 777 787 (Pubitemid 39311757)
11. M.J. Zelefsky, Z. Fuks, and L. Happersett Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer Radiother Oncol 55 2000 241 249 (Pubitemid 30408370)
12. G.O. De Meerleer, V.H. Fonteyne, and L. Vakaet Intensity-modulated radiation therapy for prostate cancer: late morbidity and results on biochemical control Radiother Oncol 82 2007 160 166
13. S.L. Liauw, R.R. Weichselbaum, and G.P. Zagaja Salvage radiotherapy after postprostatectomy biochemical failure: does pretreatment radioimmunoscintigraphy help select patients with locally confined disease? Int J Radiat Oncol Biol Phys 71 2008 1316 1321
14. M.J. Zelefsky, Z. Fuks, and S.A. Leibel Intensity-modulated radiation therapy for prostate cancer Semin Radiat Oncol 12 2002 229 237 (Pubitemid 34755929)
15. A.B. Jani, A. Su, and D. Correa Comparison of late gastrointestinal and genitourinary toxicity of prostate cancer patients undergoing intensity-modulated versus conventional radiotherapy using localized fields Prostate Cancer Prostatic Dis 10 2007 82 86 (Pubitemid 46358916)
16. M. Feng, A.L. Hanlon, and T.M. Pisansky Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy Int J Radiat Oncol Biol Phys 68 2007 1417 1423 (Pubitemid 47176790)
17. R. Choo, M. Pearse, and C. Danjoux Analysis of gastrointestinal and genitourinary morbidity of postoperative radiotherapy for pathologic T3 disease or positive surgical margins after radical prostatectomy using National Cancer Institute expanded common toxicity criteria Int J Radiat Oncol Biol Phys 72 2008 989 995
18. M. Pearse, R. Choo, and C. Danjoux Prospective assessment of gastrointestinal and genitourinary toxicity of salvage radiotherapy for patients with prostate-specific antigen relapse or local recurrence after radical prostatectomy Int J Radiat Oncol Biol Phys 72 2008 792 798
19. M. Bolla, H. van Poppel, and L. Collette Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) Lancet 366 2005 572 578 (Pubitemid 41140332)
20. G.W. Wong, K.L. Palazzi-Churas, and D.F. Jarrard Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy Int J Radiat Oncol Biol Phys 70 2008 449 455
21. J.C. Cheng, T.E. Schultheiss, and K.H. Nguyen Acute toxicity in definitive versus postprostatectomy image-guided radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 71 2008 351 357
22. J.L. Peterson, S.J. Buskirk, and M.G. Heckman Late toxicity after postprostatectomy salvage radiation therapy Radiother Oncol 93 2009 203 206
23. S.K. Nath, A.P. Sandhu, and B.S. Rose Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 78 2010 435 441
24. S. Arcangeli, B. Saracino, and M.G. Petrongari Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area Radiother Oncol 84 2007 148 155 (Pubitemid 47284530)
25. K.H. Fan, Y.C. Chen, and C.K. Chuang Preliminary treatment results of intensity-modulated radiotherapy for prostate cancer Chang Gung Med J 29 2006 313 324
26. F. Alongi, C. Fiorino, and C. Cozzarini IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with postoperative adjuvant or salvage radiotherapy after radical prostatectomy Radiother Oncol 93 2009 207 212